What one share of Alto Neuroscience holds
We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Through insights derived from our scalable and proprietary Precision Psychiatry Platform, or our Platform, we aim to discover brain-based biomarkers to better identify which patients are more likely to respond to our novel product candidates.
Alto Neuroscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.38 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$1.95 |
| Cash and investments | $6.95 |
| Debt | $0.46 |
| Book value | $6.25 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$9.73 | $0.13 | −$9.09 | — | −$18.70 |
| 2024 | — | −$2.50 | $0.08 | −$2.01 | — | $5.61 |
| 2025 | — | −$2.19 | $0.00 | −$1.80 | — | $4.73 |
Common questions about Alto Neuroscience
How much does one share of Alto Neuroscience earn?
Over the last 12 months, Alto Neuroscience lost $2.38 for each share.
Does Alto Neuroscience pay a dividend?
Alto Neuroscience didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Alto Neuroscience’s book value per share?
Alto Neuroscience’s book value is $6.25 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Alto Neuroscience have?
Each share of Alto Neuroscience has $6.95 of cash and investments and $0.46 of debt, as of June 30, 2026.
What is Alto Neuroscience’s free cash flow per share?
−$1.95 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.